Experimental Hematology
Volume 38, Issue 5 , Pages 384-391 , May 2010

F104S c-Mpl responds to a transmembrane domain−binding thrombopoietin receptor agonist: Proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents

  • Norma E. Fox

      Affiliations

    • Drs. Fox and Lim contributed equally to this work.
    • ,
  • Jihyang Lim

      Affiliations

    • Drs. Fox and Lim contributed equally to this work.
    • ,
  • Rose Chen
    • ,
  • Amy E. Geddis

      Affiliations

    • Corresponding Author InformationOffprint requests to: Amy E. Geddis, M.D., Ph.D., Pediatric Hematology-Oncology, University of California, San Diego, 9500 Gilman Drive, Mailcode 0671, La Jolla, CA 92017

Received 30 September 2009 ,Revised 10 February 2010 ,Accepted 16 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0301-472X(10)00052-4

doi: 10.1016/j.exphem.2010.02.007

Experimental Hematology
Volume 38, Issue 5 , Pages 384-391 , May 2010

Article Tools

* Image Usage & Resolution